CNBG Given Go-Ahead to Test HFMD Vaccine

China National Biotech Group Co. Ltd. received approval from the SFDA to conduct clinical trials of a vaccine for hand, foot and mouth disease. HFMD, which is caused by enterovirus 71 (EV71), is a recurrent problem in China, mainly affectiing children under the age of five. An outbreak of the disease is currently plaguing South Korea. More details....
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.